Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner (Q82973646)
Jump to navigation
Jump to search
scientific article published on 15 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner |
scientific article published on 15 December 2011 |
Statements
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner (English)
Aisha Masood
Kasyapa Chitta
Aneel Paulus
A Nazmul H Khan
Taimur Sher
Noreen Ersing
Kena C Miller
Deborah Manfredi
Sikander Ailawadhi
Ivan Borrelo
Kelvin P Lee
Asher Chanan-Khan
15 December 2011